![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1335, 2002-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin cost effective following PCI
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin cost effective following PCI
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin: A Review of its Use in Lipid Disorders
Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aspirin resistance reduces response to clopidogrel after PCI
Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. :